구강 작열감 증후군의 약물적 치료 비교 연구
Comparison of Pharmacological Treatments for Burning Mouth Syndrome
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background and Objectives Burning mouth syndrome (BMS) refers to a collection of symptoms of patients who complain about burning sensation of their mouths without any specific causes. Although this is not a rare disease, the etiology and effective treatment are not well established. We tried to compare the efficacy and side effects of the agents that are reported to be relatively effective to BMS. Subjects and Method Fifty-one patients who were diagnosed as BMS were chosen as candidates. Trazodone, Paroxetine, Clonazepam, and Gabapentin, which were known to be effective medicines for BMS in previous research were prescribed randomly. We prescribed medication for two weeks and evaluated patients for the effect and side effects at the end of the treat-ment. The medication was prescribed for 2 more weeks and the patients were evaluated again. Results Three of 11 (27.3%) patients were prescribed Trazodone, 8 of 12 (66.7%) Paroxetine, 8 of 14 (57.1%) Clonazepam and 12 of 14 (85.7%) Gabapentin. Q showed improvements after 4 weeks of medication. The differential effectiveness among the medications was not significant, except for the inferiority of Trazodone. Five of 11 (45.5%) patients who had been prescribed Trazodone, 2 of 12 (16.7%) who had been prescribed Paroxetine, 2 of 14 (14.3%) who had been prescribed Clonazepam, 2 of 14 (14.3%) who had been prescribed Gabapentin complained of side effects during 4 weeks of medication. Conclusion We can expect high success rates of treatment for burning mouth syndrome with Paroxetine, Clonazepam and Gabapentin. A further study for long term outcomes and side effects in large groups is warranted.
Abstract
Background and Objectives Burning mouth syndrome (BMS) refers to a collection of symptoms of patients who complain about burning sensation of their mouths without any specific causes. Although this is not a rare disease, the etiology and effective treatment are not well established. We tried to compare the efficacy and side effects of the agents that are reported to be relatively effective to BMS. Subjects and Method Fifty-one patients who were diagnosed as BMS were chosen as candidates. Trazodone, Paroxetine, Clonazepam, and Gabapentin, which were known to be effective medicines for BMS in previous research were prescribed randomly. We prescribed medication for two weeks and evaluated patients for the effect and side effects at the end of the treat-ment. The medication was prescribed for 2 more weeks and the patients were evaluated again. Results Three of 11 (27.3%) patients were prescribed Trazodone, 8 of 12 (66.7%) Paroxetine, 8 of 14 (57.1%) Clonazepam and 12 of 14 (85.7%) Gabapentin. Q showed improvements after 4 weeks of medication. The differential effectiveness among the medications was not significant, except for the inferiority of Trazodone. Five of 11 (45.5%) patients who had been prescribed Trazodone, 2 of 12 (16.7%) who had been prescribed Paroxetine, 2 of 14 (14.3%) who had been prescribed Clonazepam, 2 of 14 (14.3%) who had been prescribed Gabapentin complained of side effects during 4 weeks of medication. Conclusion We can expect high success rates of treatment for burning mouth syndrome with Paroxetine, Clonazepam and Gabapentin. A further study for long term outcomes and side effects in large groups is warranted.
참고문헌 (12)
- Grushka M, "Burning mouth syndrome", Am Fam Physician, 65(4), pp.615~620 (2002)
- Suarez P, "Burning mouth syndrome: an update on diagnosis and treatment methods", J Calif Dent Assoc, 34(8), pp.611~622 (2006)
- Tammiala-Salonen T, "Trazodone in burning mouth pain: a placebo-controlled, double-blind study", J Orofac Pain, 13(2), pp.83~88 (1999)
- Maina G, "Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study", J Clin Psychiatry, 63(1), pp.38~43 (2002)
- Grushka M, "An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 86(5), pp.557~561 (1998)
- Ben-David B, "Gabapentin therapy for vulvodynia", Anesth Analg, 89(6), pp.1459~1460 (1999)
- 정연훈, "구강작열감 증후군 환자의 임상적 특징 및 스테로이드 가글 치료의 예비결과", 대한이비인후과학회지 두경부외과학, 47(6), pp.569~574 (2004), 대한이비인후과학회
- Femiano F, "Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy", Med Oral, 9(1), pp.8~13 (2004)
- Femiano F, "Burning mouth syndrome (BMS): an open trial of comparative efficacy of alpha-lipoic acid (thioctic acid) with other therapies", Minerva Stomatol, 51(9), pp.405~409 (2002)
- Woda A, "A possible therapeutic solution for stomatodynia (burning mouth syndrome)", J Orofac Pain, 12(4), pp.272~278 (1998)
- Petruzzi M, "Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study", J Oral Pathol Med, 33(2), pp.111~114 (2004)
- Gremeau-Richard C, "Topical clonazepam in stomatodynia: a randomised placebo-controlled study", Pain, 108(1-2), pp.51~57 (2004)